Recombinant interferon .alpha.2 (if.alpha.2) mutants

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) C07K 14/57 (2006.01)

Patent

CA 2613737

The present invention provides IFN.alpha.2 mutants and active fragments, analogs, derivatives, and variants thereof that have improved specific agonist or antagonist activity as compared to wild-type IFN.alpha.2. The present invention further provides pharmaceutical compositions comprising IFN.alpha.2 mutants useful for treating or preventing cancer, autoimmune diseases, infectious diseases or disorders associated with increased expression of IFN.alpha.2.

La présente invention concerne des mutants IFNa2 et des fragments actifs, des analogues, des dérivés et des variants de ceux-ci qui possèdent une activité agoniste ou antagoniste spécifique améliorée comparée à IFNa2 de type sauvage. Cette invention concerne aussi des compositions pharmaceutiques comprenant des mutants IFNa2 qui conviennent pour traiter ou prévenir le cancer, des maladies auto-immunes, des maladies infectieuses ou des pathologies associées à une expression accrue de IFNa2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant interferon .alpha.2 (if.alpha.2) mutants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant interferon .alpha.2 (if.alpha.2) mutants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant interferon .alpha.2 (if.alpha.2) mutants will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1960420

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.